SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)

Translation articles:<p>R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators “Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening R...

Full description

Bibliographic Details
Main Authors: R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/166
id doaj-64a04579dfce4aa6a0df5926d041b17f
record_format Article
spelling doaj-64a04579dfce4aa6a0df5926d041b17f2020-11-25T00:32:42ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-0110110611510.1234/1819-6446-2014-1-106-115166SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)R. Eschalier0J.J.V. McMurray1K. Swedberg2D.J. Veldhuisen van3H. Krum4S.J. Pocock5H. Shi6J. Vincent7P. Rossignol8F. Zannad9B. Pitt10Центр клинических исследований, Больничный центр университета в Нанси, Национальный институт здравоохранения и медицинских исследований CIC-P 9501, Нанси; Университет Оверни, UMR6284, Отдел кардиологии, Клермон-ФерранУниверситет ГлазгоУниверситет ГетеборгаУниверситетский медицинский центр, ГронингенУниверситет Монаш, Мельбурн, шт. ВикторияЛондонская Школа гигиены и тропической медициныПфайзер, Нью-ЙоркПфайзер, Нью-ЙоркНациональный институт здравоохранения и медицинских исследований, Нанси; Университет Лотарингии, НансиНациональный институт здравоохранения и медицинских исследований, Нанси; Университет Лотарингии, Нанси; Больничный центр университета в НансиМичиганский Университет, Анн-Арбор, МичиганTranslation articles:<p>R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators “Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)”  J Am Coll Cardiol 2013;62(17):1585-93; <a href="http://dx.doi.org/10.1016/">http://dx.doi.org/10.1016/</a>j.jacc.2013.04.086</p>http://www.rpcardio.ru/jour/article/view/166хроническая болезнь почексахарный диабетэффективностьпожилые пациентыэплеренонбезопасность
collection DOAJ
language English
format Article
sources DOAJ
author R. Eschalier
J.J.V. McMurray
K. Swedberg
D.J. Veldhuisen van
H. Krum
S.J. Pocock
H. Shi
J. Vincent
P. Rossignol
F. Zannad
B. Pitt
spellingShingle R. Eschalier
J.J.V. McMurray
K. Swedberg
D.J. Veldhuisen van
H. Krum
S.J. Pocock
H. Shi
J. Vincent
P. Rossignol
F. Zannad
B. Pitt
SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
Racionalʹnaâ Farmakoterapiâ v Kardiologii
хроническая болезнь почек
сахарный диабет
эффективность
пожилые пациенты
эплеренон
безопасность
author_facet R. Eschalier
J.J.V. McMurray
K. Swedberg
D.J. Veldhuisen van
H. Krum
S.J. Pocock
H. Shi
J. Vincent
P. Rossignol
F. Zannad
B. Pitt
author_sort R. Eschalier
title SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
title_short SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
title_full SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
title_fullStr SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
title_full_unstemmed SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
title_sort safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function. analyses of the emphasis-hf study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure)
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-09-01
description Translation articles:<p>R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators “Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)”  J Am Coll Cardiol 2013;62(17):1585-93; <a href="http://dx.doi.org/10.1016/">http://dx.doi.org/10.1016/</a>j.jacc.2013.04.086</p>
topic хроническая болезнь почек
сахарный диабет
эффективность
пожилые пациенты
эплеренон
безопасность
url http://www.rpcardio.ru/jour/article/view/166
work_keys_str_mv AT reschalier safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT jjvmcmurray safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT kswedberg safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT djveldhuisenvan safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT hkrum safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT sjpocock safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT hshi safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT jvincent safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT prossignol safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT fzannad safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
AT bpitt safetyandefficacyofeplerenoneinpatientsathighriskforhyperkalemiaandorworseningrenalfunctionanalysesoftheemphasishfstudysubgroupseplerenoneinmildpatientshospitalizationandsurvivalstudyinheartfailure
_version_ 1725319454573723648